GRAIL Poaches New CEO From Roche, Genentech Post author:Sam Post published:December 13, 2017 Post category:BioPharma Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement. Source: BioSpace You Might Also Like GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … October 22, 2017 PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update May 11, 2017 <b>EBS Technologies</b> Appoints <b>Karl Schweitzer</b> As Chief Executive Officer August 27, 2017
GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … October 22, 2017